Long Noncoding RNA MALAT-1: A Versatile Regulator in Cancer Progression, Metastasis, Immunity, and Therapeutic Resistance

Overview

Journal Noncoding RNA Res

Date 2024 Mar 21

PMID 38511067

Authors

Dexin Xu

Wenhai Wang

Duo Wang

Jian Ding

Yunan Zhou

Wenbin Zhang

Affiliations

Soon will be listed here.

Abstract

Long noncoding RNAs (lncRNAs) are RNA transcripts longer than 200 nucleotides that do not code for proteins but have been linked to cancer development and metastasis. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1) influences crucial cancer hallmarks through intricate molecular mechanisms, including proliferation, invasion, angiogenesis, apoptosis, and the epithelial-mesenchymal transition (EMT). The current article highlights the involvement of MALAT-1 in drug resistance, making it a potential target to overcome chemotherapy refractoriness. It discusses the impact of MALAT-1 on immunomodulatory molecules, such as major histocompatibility complex (MHC) proteins and PD-L1, leading to immune evasion and hindering anti-tumor immune responses. MALAT-1 also plays a significant role in cancer immunology by regulating diverse immune cell populations. In summary, MALAT-1 is a versatile cancer regulator, influencing tumorigenesis, chemoresistance, and immunotherapy responses. Understanding its precise molecular mechanisms is crucial for developing targeted therapies, and therapeutic strategies targeting MALAT-1 show promise for improving cancer treatment outcomes. However, further research is needed to fully uncover the role of MALAT-1 in cancer biology and translate these findings into clinical applications.

Citing Articles

Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma.

Jin P, Bai X IBRO Neurosci Rep. 2025; 18:323-337.

PMID: 40034544 PMC: 11872630. DOI: 10.1016/j.ibneur.2025.01.015.

Inhibition of MALAT1 facilitates ROS accumulation via the Keap1/HO-1 pathway to enhance photodynamic therapy in secondary hyperparathyroidism.

Wen Y, Li Y, Zhang D, Liu Z, Liu H, Li X Noncoding RNA Res. 2025; 11:249-261.

PMID: 39896343 PMC: 11787669. DOI: 10.1016/j.ncrna.2024.12.001.

HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer.

Nishiyama H, Niinuma T, Kitajima H, Ishiguro K, Yamamoto E, Sudo G Int J Mol Sci. 2024; 25(23).

PMID: 39684631 PMC: 11641524. DOI: 10.3390/ijms252312920.

Regulation and Therapeutic Application of Long non-Coding RNA in Tumor Angiogenesis.

Zhang S, Xia Y, Chen W, Dong H, Cui B, Liu C Technol Cancer Res Treat. 2024; 23:15330338241273239.

PMID: 39110070 PMC: 11307360. DOI: 10.1177/15330338241273239.

References

Zhang D, Fang C, Li H, Lu C, Huang J, Pan J . Long ncRNA MALAT1 promotes cell proliferation, migration, and invasion in prostate cancer via sponging miR-145. Transl Androl Urol. 2021; 10(6):2307-2319. PMC: 8261405. DOI: 10.21037/tau-20-1526. View

Colombo N, Sessa C, Bois A, Ledermann J, McCluggage W, McNeish I . ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol. 2019; 30(5):672-705. DOI: 10.1093/annonc/mdz062. View

Amer H, Eissa R, El Tayebi H . A cutting-edge immunomodulatory interlinkage between HOTAIR and MALAT1 in tumor-associated macrophages in breast cancer: A personalized immunotherapeutic approach. Front Mol Biosci. 2022; 9:1032517. PMC: 9649622. DOI: 10.3389/fmolb.2022.1032517. View

Golomb L, Bublik D, Wilder S, Nevo R, Kiss V, Grabusic K . Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. Mol Cell. 2012; 45(2):222-32. PMC: 3270374. DOI: 10.1016/j.molcel.2011.11.022. View

Asim M, Massie C, Orafidiya F, Pertega-Gomes N, Warren A, Esmaeili M . Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target. J Natl Cancer Inst. 2015; 108(5). PMC: 4849803. DOI: 10.1093/jnci/djv371. View

Zhang J, Li Q, Xue B, He R . MALAT1 inhibits the Wnt/β-catenin signaling pathway in colon cancer cells and affects cell proliferation and apoptosis. Bosn J Basic Med Sci. 2019; 20(3):357-364. PMC: 7416178. DOI: 10.17305/bjbms.2019.4408. View

Qiu J, Lin X, Tang X, Zheng T, Lin Y, Hua K . Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer. Int J Biol Sci. 2018; 14(14):1960-1973. PMC: 6299373. DOI: 10.7150/ijbs.28048. View

Zeitels L, Acharya A, Shi G, Chivukula D, Chivukula R, Anandam J . Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis. Genes Dev. 2014; 28(23):2585-90. PMC: 4248289. DOI: 10.1101/gad.250951.114. View

He P, He C . m A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021; 40(3):e105977. PMC: 7849164. DOI: 10.15252/embj.2020105977. View

10.

Hu Z, Ma D . The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018; 7(10):5217-5236. PMC: 6198240. DOI: 10.1002/cam4.1501. View

11.

Huang X, Xia Y, He G, Zheng L, Cai Y, Yin Y . MALAT1 promotes angiogenesis of breast cancer. Oncol Rep. 2018; 40(5):2683-2689. DOI: 10.3892/or.2018.6705. View

12.

Wei S, Wang K, Huang X, Zhao Z, Zhao Z . LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis. Int J Immunopathol Pharmacol. 2019; 33:2058738419859699. PMC: 6595645. DOI: 10.1177/2058738419859699. View

13.

Hu J, Zhang L, Mei Z, Jiang Y, Yi Y, Liu L . Interaction of E3 Ubiquitin Ligase MARCH7 with Long Noncoding RNA MALAT1 and Autophagy-Related Protein ATG7 Promotes Autophagy and Invasion in Ovarian Cancer. Cell Physiol Biochem. 2018; 47(2):654-666. DOI: 10.1159/000490020. View

14.

Song Z, Wang X, Chen F, Chen Q, Liu W, Yang X . LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. Front Oncol. 2022; 12:1004212. PMC: 9533337. DOI: 10.3389/fonc.2022.1004212. View

15.

Yang L, Bai H, Deng Y, Fan L . High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 2015; 19(17):3187-93. View

16.

Zhang Z, Tang C, Dong Y, Zhang J, Yuan T, Li X . Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin. J Cancer. 2018; 9(1):71-80. PMC: 5743713. DOI: 10.7150/jca.22113. View

17.

Zhou Y, Xu X, Lv H, Wen Q, Li J, Tan L . The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration. PLoS One. 2016; 11(5):e0155250. PMC: 4881927. DOI: 10.1371/journal.pone.0155250. View

18.

Lin L, Yan L, Liu Y, Qu C, Ni J, Li H . The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017. Liver Cancer. 2020; 9(5):563-582. PMC: 7548973. DOI: 10.1159/000508568. View

19.

Nedeljkovic M, Damjanovic A . Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge. Cells. 2019; 8(9). PMC: 6770896. DOI: 10.3390/cells8090957. View

20.

Asim M, Massie C, Neal D . Kinase joins the chaperone club: Androgen-regulated kinome reveals choline kinase alpha as a potential drug target in prostate cancer. Mol Cell Oncol. 2016; 3(3):e1140262. PMC: 4909410. DOI: 10.1080/23723556.2016.1140262. View